Clinical Trial Update: Clinical Trial of the TQB2102 Injection in Patients With Advanced Cancers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating TQB2102 Injection in patients with advanced cancer; the trial status is ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• TQB2102 Injection

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Conditions: Advanced Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING